{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihnnfl75uharg722lssjwhw5pyuminwqmyljaen3hjxmmdmqnizxm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3ml24cmiadjs2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/04/abortion-pill-mifepristone-controversy-ucb-deal/?utm_campaign=rss",
  "publishedAt": "2026-05-04T13:58:35.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Two drugmakers asked the U.S. Supreme Court to restore mail-order access to the abortion pill mifepristone, after an appeals court suspended deliveries",
  "title": "STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news",
  "updatedAt": "2026-05-04T13:58:40.000Z"
}